Pregnancy is a unique immunological state with an everchanging balance in immune responses.
serum, and C-reactive protein (CRP) levels in serum have been identified as risk factors for preterm birth (PTB) <32 weeks. [21] [22] [23] [24] In addition, infants identified as small for gestational age have been associated with low proinflammatory and anti-inflammatory maternal serum cytokines.
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Research by Heng et al (2014) explored biomarkers in CVF as potential predictors for term and preterm labors, and concluded the medium to be an excellent source to study cytokine changes throughout pregnancy, noting the importance of multiple biomarker modeling to achieve predictive efficacy. 26, 27 In addition to cytokines, there is evidence of increased expression of chemokines, as well as increased activity of select matrix metalloproteinases (MMPs 8 and 9) in spontaneous PTB and rupture of membranes. 28 Further, cytokine-induced MMP expression can be inhibited due to the effect of progesterone on the decidua; thus, contributing to a potential dysregulation in the host response. 29 Given the complexity of the immune responses and the importance in normal and adverse pregnancy outcomes, describing the status of cytokines throughout pregnancy in both CVF and serum is a necessary precursor for elucidating which biomarker(s) may serve best to predict adverse events.
Materials and Methods

Human Samples
This study reports the analysis of a multicenter, prospective, longitudinal study of women with a singleton gestation.
Patients were screened at the University of Kentucky and University of Virginia prenatal clinics to exclude any preexisting diabetes, heart disease, a medical history of HIV, bacterial vaginosis, sexually transmitted infections, chronic conditions with implications for immune function, any autoimmune disease, or illicit drug use. The Institutional Review Boards at the affiliated sites approved the study protocol. Informed written consent for the study was obtained, and all of the women volunteers received modest compensation for participation. Maternal serum (288, 243, and 221 patients) and CVF (273, 229, and 198 patients) were collected during each trimester to measure the following cytokine levels: IL-1α, IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-α, and CRP. For MMP-8 cytokine data, serum was collected from 205, 170, and 152, and CVF from 185, 156, and 128 patients during the three trimesters, respectively. Participant age, number of prior pregnancies (parity), race, education, and income were collected by self-report. Body mass index (BMI) was calculated from the patient's height and weight recordings.
Sample Collection and Cytokine Estimation
Clotted blood samples were centrifuged at 2,000 rpm for 10 minutes, and the serum was divided into three aliquots and stored at À80°C. Samples were analyzed undiluted. For CVF specimens, samples were obtained after the speculum was placed and the cervix visualized. An ectocervical sample was collected using an Aware Messenger (Calypte) swab and by sweeping the cervix 360 degrees and kept in place for 30 seconds to maximize saturation. When removing the swab, a vaginal sample was obtained by sweeping 360 degrees in the vaginal vault/posterior fornix. The swab was then placed in the proprietary container, firmly pressed against the inner cryovial wall to ensure maximum seepage of fluid into the buffer container, and the vial cap secured. All samples were immediately refrigerated, transported to the laboratory within 6 hours where they were stored at À20°C for a minimum of 24 hours. To further process, samples were thawed 4°C, and then centrifuged at 3,750 rpm for 15 minutes. For long-term storage, the samples were split into three aliquots and stored at À80°C. Cytokines IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNF-α were measured using multiplex Beadlyte assay (MPXHCYTO-60K-06) on a Luminex IS-100 (Austin, TX) according to the manufacturer's recommendations. High sensitivity testing was used for samples below minimum detectable concentrations. Singleplex assays were used for CRP (Millipore, Billerica, MA) and MMP-8 (R&D Systems, Minneapolis, MN). The dynamic range of the CRP assay was 50 to 0.016 ng/mL with a minimum detection concentration of 0.0012 ng/mL, and MMP-8 range was 66,700 to 91.5 pg/ml with a MinDC of 16.6 pg/mL (samples were diluted 1:10 from MMP-8 analysis). All cytokine data were generated using Milliplex Analyst Software.
Statistical Analysis
The nonnormally distributed raw cytokine levels were log transformed prior to all analysis. Pearson's product moment correlation was used to determine associations among cytokines by medium (serum vs. CVF) and trimester, Two-factor linear mixed modeling evaluated differences in cytokine levels between sources and over time. The first factor was cytokine source (serum/cervicovaginal) and the second factor was trimester (first/second/third). Each model contained the main effects for cytokine source and trimester as well as their interaction. If the interaction term was not significant in the model, it was removed and the model with only main effects was subsequently fit. In all models, women were included as a random factor to account for repeated measures on individuals over time. All data analysis were conducted using SAS, version 9.4, with an α level of 0.05.
Results
Patient demographic and clinical characteristics are summarized in ►Table 1. The majority was white/non-Hispanic (74%) and had at least a high school diploma/General Education Development (GED) (87%). Median parity among this sample was one (interquartile range ¼ 1-3) and average BMI was 26 AE 6.4 kg/m 2 . At enrollment, 66 women (20%) had a history of prior PTB and 25 women (4.8%) had a history of preeclampsia. The overall rate of PTB was 13.9% for the cohort, with nearly 10% experiencing spontaneous PTB.
Correlations among Cytokines at Each Trimester
Pearson's correlations were conducted to determine the patterns of association among cytokines in serum and CVF separately. Most of the serum cytokines, with the exception of interleukins and CRP, and almost all of the CVF cytokines were positively and significantly correlated with each other, for each trimester (see ►Tables 2 and 3). 
Overall Changes in Cytokines Levels over Time
The cytokine levels, both from serum and CVF, demonstrated significant variations across pregnancy. There were no differences in the rate of change between serum and CVF cytokines across trimesters (i.e., each of the interactions between trimester and source were nonsignificant) for any cytokine except TNF-α. Therefore, averaging across trimester, concentrations of CVF IL-1β, IL-6, IL-8, IL-1α, and MMP-8 (p < 0.001 for all comparisons; ►Figs. 1-5, respectively) were significantly greater than serum levels, while concentrations of serum IL-10 and CRP (p < 0.001 for all comparisons; ►Figs. 6 and 7, respectively) were significantly greater than CVF levels.
Regardless of source (CVF or serum), concentrations significantly varied across trimester for IL-8, MMP-8, and IL-10. There was no change in IL-8 from first to second trimester, but there were significant increases in concentrations from first to third (p ¼ 0.006) and second to third (p ¼ 0.03) trimesters. MMP-8 levels significantly increased from first to third (p ¼ 0.013) trimester; however, the changes from first to second and second to third trimesters were not significant. Concentrations for IL-10 increased significantly from first to second (p < 0.001) and first to third trimesters (p < 0.001); the change from second to third trimester was not significant. Concentrations did not significantly vary across trimester for IL-6, IL-1α, IL-1β, or CRP. The interaction between cytokine and trimester was significant for TNF-α (p < 0.001; ►Fig. 8). CVF concentrations were significantly lower at each trimester compared with serum (p < 0.001 for all three comparisons). In comparing changes in CVF TNF-α concentrations over time, there was a significant decrease from first to second (p ¼ 0.048) and first to third (p ¼ 0.002) trimesters, although levels did not differ between second and third trimesters. Among serum TNF-α concentrations, there was a significant increase from first to third (p ¼ 0.004) trimester, but the changes from first to second and second to third trimesters were not significant.
Discussion
Our data confirm proinflammatory and anti-inflammatory cytokine concentrations vary in distribution across pregnancy, although changes in cytokine levels across gestation have not been well delineated previously. In this study, we analyzed cytokine concentrations in serum and CVF. IL-1β, IL-6, IL-8, and MMP-8 concentrations were significantly higher in CVF than serum, while IL-1α, IL-10, and CRP were significantly higher in serum. The differences between serum and CVF concentrations of TNF-α varied by trimester. Of note, IL-10, an important anti-inflammatory cytokine for immune modulation increased significantly from early to late pregnancy, which is consistent with a report by Coussons-Read et al. 30 In our data, TNF-α also significantly increased in serum from the first to the third trimester of pregnancy consistent with previous reports. 30, 31 Finally, our data are supported by a report by Larsson et al who noted that serum CRP concentrations increase consistently throughout pregnancy.
32
Cervicovaginal specimens may provide additional and more selective alterations in the immune response within the reproductive tract. Hence, we also aimed to describe variation in cytokine distribution at this mucosal surface. Interestingly, in contrast to serum, CVF CRP concentration decreased in middle as compared with early and late pregnancy samples. Potentially, the increasing levels of MMP-8 in TNF-α (log-transformed) levels varied significantly across pregnancy between serum and CVF specimens (p < 0.001 from F-test of fixed effects for the interaction). In the post hoc analysis, within the CVF, first trimester levels were significantly higher than second and third trimester levels (p ¼ 0.048 and p ¼ 0.002, respectively). Within the serum, first trimester levels were significantly lower than third trimester levels (p ¼ 0.004). At each trimester, concentrations of TNF-α were significantly lower in the CVF compared with serum specimens (p < 0.001 for all comparisons). CVF, cervicovaginal fluid; TNF, tumor necrosis factor.
CVF from early to late pregnancy may reflect its biological function as a collagen-cleaving enzyme in preparation for labor, though does not appear to be involved during the labor process. 33 IL-6 has been identified as a main cytokine associated with adverse perinatal health outcomes. [34] [35] [36] [37] In this study, significantly higher levels of IL-6 in CVF versus serum suggest cervicovaginal specimens may allow better discrimination between normal and pathologic conditions. IL-6 concentrations did not vary significantly across the pregnancy timeline in this study. Similar to Heng et al (2014) , there were no significant changes in CVF IL-1α in second and third trimester samples.
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This research is one of the first projects to compare trimester-specific immune markers in two biological fluids. One strength of this study is the longitudinal design, which assessed women with singleton gestation at each trimester. A weakness is the attrition observed throughout the trimesters and lack of control for exposures such as antibiotics. In addition, varied collection times within the trimesters (limited to a 6-week window per protocol) may have influenced the variation for determination of the interpersonal gestational immunological changes.
Despite these concerns, our findings provide a framework for examining patterns of changes in cytokines over the time course of pregnancy. Further research to measure the range of maternal and fetal immune responsiveness during gestation is warranted, particularly in response to pathophysiologies occurring early in pregnancy. 
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